Stericycle, Inc. (NASDAQ:SRCL)‘s stock had its “ourperform” rating reiterated by research analysts at William Blair in a research report issued on Thursday.

A number of other brokerages have also recently commented on SRCL. Zacks Investment Research cut Stericycle from a “buy” rating to a “hold” rating in a report on Monday, August 7th. BidaskClub cut Stericycle from a “sell” rating to a “strong sell” rating in a report on Tuesday, August 1st. Jefferies Group LLC reissued a “buy” rating and set a $108.00 target price on shares of Stericycle in a report on Thursday, July 13th. Barclays PLC reissued an “overweight” rating and set a $100.00 target price on shares of Stericycle in a report on Wednesday, August 9th. Finally, BMO Capital Markets initiated coverage on Stericycle in a report on Thursday, June 29th. They set a “market perform” rating and a $81.00 target price for the company. Three analysts have rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $81.25.

Stericycle (NASDAQ:SRCL) traded down 0.57% during mid-day trading on Thursday, reaching $71.72. The company’s stock had a trading volume of 135,389 shares. The company’s market cap is $6.12 billion. Stericycle has a 12-month low of $68.62 and a 12-month high of $88.00. The firm’s 50 day moving average is $73.42 and its 200-day moving average is $79.27.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings results on Thursday, August 3rd. The business services provider reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.13 by $0.02. Stericycle had a positive return on equity of 14.35% and a negative net margin of 0.07%. The company had revenue of $917.70 million for the quarter, compared to the consensus estimate of $902.81 million. During the same quarter in the prior year, the business posted $1.18 earnings per share. Stericycle’s revenue for the quarter was up 2.9% on a year-over-year basis. Equities analysts anticipate that Stericycle will post $4.60 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Stericycle, Inc. (SRCL) Receives Ourperform Rating from William Blair” was first published by American Banking News and is the property of of American Banking News. If you are accessing this article on another site, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/09/14/stericycle-inc-srcl-receives-ourperform-rating-from-william-blair.html.

Several large investors have recently bought and sold shares of SRCL. BlackRock Inc. increased its holdings in shares of Stericycle by 3,492.3% in the first quarter. BlackRock Inc. now owns 5,089,580 shares of the business services provider’s stock valued at $421,877,000 after purchasing an additional 4,947,900 shares during the last quarter. Ameriprise Financial Inc. increased its holdings in shares of Stericycle by 144.9% in the first quarter. Ameriprise Financial Inc. now owns 1,901,243 shares of the business services provider’s stock valued at $157,594,000 after purchasing an additional 1,124,908 shares during the last quarter. Schroder Investment Management Group acquired a new stake in shares of Stericycle in the second quarter valued at approximately $80,497,000. Thompson Siegel & Walmsley LLC acquired a new stake in shares of Stericycle in the second quarter valued at approximately $33,710,000. Finally, Morgan Stanley increased its holdings in shares of Stericycle by 110.4% in the first quarter. Morgan Stanley now owns 625,893 shares of the business services provider’s stock valued at $51,881,000 after purchasing an additional 328,431 shares during the last quarter. 93.72% of the stock is owned by hedge funds and other institutional investors.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.